Corneal Collagen Crosslinking Techniques for Keratoconus Treatment

Keratoconus is a progressive corneal ectasia characterised by stromal thinning, anterior protrusion and irregular astigmatism leading to visual impairment. Corneal collagen crosslinking (CXL) has emerged as the only intervention that directly targets tissue biomechanics, inducing additional covalent bonds between collagen fibrils to halt or slow disease progression. Conventional CXL employs riboflavin instillation followed by ultraviolet-A (UVA) irradiation over 30 minutes, whereas accelerated protocols increase UVA intensity to reduce treatment time. Modifications such as pulsed light application and oxygen-generating adjuvants aim to optimise reactive oxygen species (ROS) generation and deepen stromal reinforcement. Clinical outcomes demonstrate improved corneal rigidity, stabilisation of maximum keratometry and gains in uncorrected and best-corrected visual acuity, with a generally favourable safety profile when epithelium removal and postoperative care are properly managed. Emerging materials and delivery approaches seek to overcome residual limitations, including hypoxia under high-fluence UVA and epithelial regeneration dynamics, further extending CXL indications to paediatric cohorts and non-keratoconic ectasias.

Research from Nature Portfolio

Recent work has introduced oxygen-self-sufficient nanoplatforms to enhance accelerated CXL. Photocatalytic quantum dots based on graphitic carbon nitride generate stromal oxygen under UVA exposure, mitigating hypoxia that limits crosslink density during high-intensity protocols. Preclinical evaluation in animal models showed superior biomechanical stiffening compared with standard riboflavin-UVA alone, suggesting a route to shorter, yet equally efficacious, treatments. In addition, comparative analyses of conventional and accelerated regimens have clarified dose–response relationships: although both protocols yield significant keratometric flattening and visual acuity improvements at one year, conventional irradiation maintains a modest edge in topographic regularisation. Such findings underpin refinement of clinical guidelines, balancing throughput and tissue response to individual corneal profiles.

Corneal Collagen Crosslinking Techniques for Keratoconus Treatment publication trend

The graph below shows the total number of articles in corneal collagen crosslinking techniques for keratoconus treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Keratoconus: A non-inflammatory ectatic disorder of the cornea characterised by stromal thinning and conical protrusion.

Corneal collagen crosslinking (CXL): A technique combining photosensitiser (riboflavin) and UVA light to induce covalent bonds between collagen fibres, thereby increasing corneal stiffness.

Accelerated CXL: A protocol that uses higher UVA irradiance over a shorter duration, guided by the Bunsen–Roscoe reciprocity law to maintain crosslinking efficacy.

Epithelium-off: A CXL approach involving removal of the corneal epithelium to enhance riboflavin stromal penetration.

Reactive oxygen species (ROS): Chemically reactive molecules generated during riboflavin-UVA interaction that drive covalent bond formation in the corneal stroma.

References

1. Development of graphitic carbon nitride quantum dots-based oxygen self-sufficient platforms for enhanced corneal crosslinking. Nature Communications (2024).
2. Crosslinking with UV-A and riboflavin in progressive keratoconus: From laboratory to clinical practice – Developments over 25 years. Progress in Retinal and Eye Research (2024).
3. Effects of Ultraviolet-A and Riboflavin on the Interaction of Collagen and Proteoglycans during Corneal Cross-linking*. Journal of Biological Chemistry (2011).
4. Pulsed Light Accelerated Crosslinking versus Continuous Light Accelerated Crosslinking: One‐Year Results. Journal of Ophthalmology (2014).
5. One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Scientific Reports (2015).
6. Accelerated Corneal Collagen Cross‐Linking in Pediatric Patients: Two‐Year Follow‐Up Results. BioMed Research International (2014).
7. In Vivo Early Corneal Biomechanical Changes After Corneal Cross-linking in Patients With Progressive Keratoconus.. Journal of Refractive Surgery (2017).